Deafferentation Pain
Deafferentation pain, a challenging category of neuropathic pain, is defined by the partial or complete interruption (deafferentation) of normal afferent sensory input from a specific body part to the central nervous system (CNS). It arises from nervous system dysfunction itself, rather than from nociceptor activation by tissue damage or inflammation. These syndromes present a significant clinical challenge due to their complex pathophysiology, severity, persistence, and frequent refractoriness to conventional treatments.[1]
Terminology
Neuropathic Pain: The term "neuropathic pain," as defined by the International Association for the Study of Pain (IASP), is the preferred overarching classification: "An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage".
Deafferentation Pain: The term "deafferentation pain" is used more specifically within this category to emphasize the critical pathophysiological element of sensory input loss.
Paroxysmal Pain: A pain paroxysm is a sudden-onset, excruciating and usually brief and well-localized pain that can occur spontaneously with no obvious precipitating event or in response to a trigger stimulus. Patients with deafferentation may have both continuous neuropathic pain plus paroxysmal pain.
Deafferentation vs neurectomy: Considering neuropathic pain followin limb amputation is useful in thinking about the differences betwen neurectomy and deafferentation. While limb amputation. does involve nerve transection (neurectomy), the resulting pain syndrome is classically considered examples of deafferentation pain.
- Deafferentation (Phantom Limb Pain): This type of pain arises as a consequence of the loss (partial or complete interruption) of normal sensory input from a body part to the central nervous system. Limb amputation inherently causes a loss of sensory input from the missing limb, and this lack of normal input triggers maladaptive plastic changes within the CNS (both the brain and spinal cord). These central changes include neuronal hyperexcitability, central sensitization, and cortical reorganization. Thus PLP, the pain perceived as originating from the missing limb, is considered the archetypal example of deafferentation pain resulting from these central changes driven by the loss of input.
- Neurectomy (Residual Limb Pain): Patients can also get Residual Limb Pain (RLP) from the neurectomy, also called neuroma pain.This type of pain is primarily driven by peripheral mechanisms resulting directly from the nerve transection itself. When a peripheral nerve is cut, the proximal end attempts to regenerate, often forming a disorganized mass of nerve sprouts called a neuroma. These neuromas, along with the damaged nerve endings at the stump, can become hyperexcitable and generate spontaneous, abnormal electrical signals (ectopic discharges). This peripheral activity is thought to be the main driver of pain localized to the residual limb (stump), often referred to as RLP or neuroma pain. It's typically characterized by localised tenderness, sharp or shooting pain, and may be exacerbated by pressure on the stump or neuroma.
The Paradox of Pain with Sensory Loss
A central and often perplexing clinical feature of deafferentation pain is its paradoxical presentation: patients experience significant, often spontaneous, pain that is localized to a body region exhibiting markedly reduced or entirely absent sensation (hypoesthesia/anesthesia, hypoalgesia/analgesia) to external stimuli. This contrasts sharply with nociceptive pain, where pain intensity generally correlates with stimulus intensity and relies on intact sensory pathways. Patients may describe severe burning, shooting, or aching sensations in an area that feels numb or has diminished sensitivity to touch, pinprick, or temperature.[2]
An extreme manifestation of this paradox is Anesthesia Dolorosa (AD), literally "painful numbness". AD is characterized by constant, severe, often burning or aching pain felt within an area that is completely numb to all sensory modalities. It most commonly occurs as a complication following surgical or traumatic injury to the trigeminal nerve.
The coexistence of pain and sensory loss is a crucial diagnostic pointer. It strongly suggests that the pain mechanism is not driven by ongoing peripheral nociception but rather by pathological changes within the somatosensory pathways themselves, consequent to the loss of normal input. The nervous system, deprived of its usual sensory signals, undergoes maladaptive changes that generate aberrant pain signals centrally.[1]
Note on the the Dorsal Root Ganglion (DRG): Deafferentation pain can result from DRG damage or loss (e.g., brachial plexus avulsion). However, the definition hinges on interrupted afferent signal flow, not necessarily DRG destruction. In typical limb amputation, the peripheral axon is severed distal to the often-surviving DRG. This cessation of normal sensory input still constitutes deafferentation. Furthermore, central lesions (stroke, spinal cord injury) can cause deafferentation pain with unaffected DRGs.
Aetiology
Injuries or diseases primarily affecting the peripheral nervous system are common causes of deafferentation pain.
Peripheral Causes
Injuries or diseases primarily affecting the peripheral nervous system are common causes of deafferentation pain.
Limb Amputation: This is perhaps the most widely recognized cause, leading to Phantom Limb Pain (PLP), where pain is perceived as originating from the missing limb. PLP is a classic example of deafferentation pain, occurring in a high percentage of amputees.
Peripheral Nerve Injury/Avulsion: Traumatic injuries causing complete or partial severance, stretching, or avulsion (tearing away from the spinal cord) of peripheral nerves or plexuses are significant causes. Brachial plexus avulsion (BPA), often resulting from high-velocity trauma, is particularly notorious for causing severe, intractable deafferentation pain in the affected arm. Painful traumatic mononeuropathies can also have a deafferentation component.
Postherpetic Neuralgia (PHN): Following an outbreak of herpes zoster (shingles), the varicella-zoster virus can damage sensory nerves and ganglia, leading to persistent neuropathic pain in the affected dermatome. This often involves significant sensory loss, classifying it as a deafferentation syndrome.
Painful Polyneuropathies: While many polyneuropathies (e.g., diabetic neuropathy) involve ongoing nerve dysfunction and inflammation, severe forms with significant axonal loss can lead to substantial sensory deficits. When pain coexists with this sensory loss, a deafferentation mechanism likely contributes to the overall pain picture.
Post-Surgical Pain/Neurectomy: Surgical procedures can inadvertently damage peripheral nerves. Furthermore, intentional nerve transection (neurectomy) or ablation procedures, sometimes performed to treat other pain conditions (like trigeminal neuralgia), can themselves result in deafferentation pain. Anesthesia Dolorosa, severe pain in a numb area of the face, is a dreaded complication specifically associated with procedures targeting the trigeminal nerve or ganglion. Phantom tooth pain following dental extraction or root canal treatment is another example.[3]
Central Causes
Lesions within the brain or spinal cord that disrupt somatosensory pathways are major causes of central deafferentation pain.
Spinal Cord Injury (SCI): SCI is a very frequent cause of chronic pain, much of which is neuropathic. Deafferentation pain following SCI typically occurs below the level of the lesion, resulting from the interruption of ascending sensory tracts (e.g., spinothalamic tract). Individuals with SCI have the highest risk of developing central neuropathic pain (CNP).[4]
Stroke: Cerebrovascular accidents causing damage to central somatosensory structures are a leading cause of CNP globally.[4] Lesions involving the thalamus (particularly the ventral posterior nucleus) can lead to the classic "thalamic pain syndrome" (Dejerine-Roussy syndrome), but lesions in the brainstem, internal capsule, or somatosensory cortex can also result in Central Post-Stroke Pain (CPSP) with deafferentation features.
Multiple Sclerosis (MS): This autoimmune disease causes demyelinating plaques within the CNS. When these lesions affect somatosensory pathways (e.g., spinal cord tracts, brainstem, thalamus), they can produce central neuropathic pain, often with associated sensory loss, consistent with a deafferentation mechanism.
Brain Injury: Traumatic brain injury (TBI) or damage from neurosurgical procedures affecting central sensory processing areas can also lead to deafferentation pain.[4]
Syringomyelia: The formation of a fluid-filled cavity (syrinx) within the spinal cord can disrupt crossing spinothalamic fibers and other sensory pathways, causing pain and sensory loss, sometimes manifesting as deafferentation pain.
Pathophysiology
Deafferentation involves a cascade of maladaptive plastic changes at multiple neuraxis levels following sensory input loss, transforming the somatosensory system to generate spontaneous pain and pathologically amplified responses.
Key Pathophysiological Changes in Deafferentation Pain
Nervous System Level | Key Mechanisms | Consequence/Contribution to Pain Phenotype |
Peripheral | Spontaneous pain signals; lowered firing threshold; peripheral sensitization; contribution to central sensitization | |
Spinal Cord | Lowered pain thresholds; allodynia; hyperalgesia; expanded receptive fields; spontaneous pain; impaired pain modulation; maintenance of chronic pain state | |
Supraspinal | Spontaneous pain; altered sensory processing; potential contribution to pain intensity (correlation); altered pain perception (sensory/affective); sensory-motor conflict; widespread network dysfunction |
PNS Contributions
Although deafferentation pain is often conceptualized as a central phenomenon resulting from loss of input, changes in the remaining peripheral nerve elements can play a significant initiating and contributing role, particularly after peripheral nerve injury or amputation.
- Ectopic Activity: Severed axons attempt to regenerate, often forming disorganized tangles of nerve sprouts known as neuromas at the injury site.[9] These damaged axons and neuroma sprouts can become hyperexcitable, generating spontaneous, aberrant action potentials (ectopic discharges) that bombard the CNS.[2] While this peripheral ectopic activity is considered the primary driver of localized neuroma pain or residual limb pain[6], this abnormal input can contribute to the induction and maintenance of central sensitization, thereby influencing deafferentation pain phenomena like PLP. This interplay highlights that even in centrally mediated deafferentation pain, addressing ongoing aberrant peripheral input, if present, can be relevant.
- Ion Channel Changes: Nerve injury triggers alterations in the expression, distribution, and kinetics of various ion channels, particularly voltage-gated sodium channels (VGSCs), on the membranes of damaged axons and associated dorsal root ganglion (DRG) neurons.[2] Increased density or altered function of specific VGSC subtypes (e.g., Nav1.3, Nav1.7, Nav1.8) lowers the threshold for neuronal firing and promotes repetitive or spontaneous discharges.
- Inflammation: Axonal damage initiates a local inflammatory response involving the release of mediators from damaged cells, resident immune cells (macrophages), and Schwann cells. Cytokines (e.g., TNF-α, IL-1β), chemokines, bradykinin, and nerve growth factor (NGF) can directly activate and sensitize the peripheral terminals of nociceptors (peripheral sensitization), contributing to ectopic firing and hyperalgesia.[5]
Spinal Cord Contributions
The dorsal horn of the spinal cord is a critical site for maladaptive plasticity following deafferentation.
- Dorsal Horn Hyperexcitability and Central Sensitization: The reduction or loss of normal afferent input, coupled with potential bombardment by ectopic signals from injured peripheral nerves, leads to profound functional changes in dorsal horn neurons, particularly in laminae associated with pain processing (I, II, V).[2] Neurons become hyperexcitable, exhibiting increased spontaneous firing rates and heightened responsiveness to remaining or inappropriate inputs.[10] This state, known as central sensitization, involves a reduction in activation thresholds, an amplification of responses to noxious stimuli (hyperalgesia), the recruitment of responses to normally innocuous stimuli (allodynia, often mediated by Aβ fibers), and an expansion of receptive field sizes.[11][2]
- Structural Reorganization: Following deafferentation, there is evidence for anatomical reorganization within the dorsal horn. Intact primary afferent fibers, particularly low-threshold mechanoreceptive Aβ fibers whose central terminals normally reside in deeper laminae, may sprout into the deafferented superficial laminae (e.g., lamina II), where nociceptive neurons are concentrated.[6] This aberrant sprouting could establish novel excitatory circuits, allowing tactile stimuli to activate pain pathways, contributing to allodynia.
- Neurotransmitter and Receptor Dysregulation: Deafferentation triggers complex changes in neurochemical signaling within the dorsal horn. This includes alterations in the synthesis and release of neurotransmitters and neuromodulators (e.g., decreased Substance P initially, potential upregulation of NPY). Postsynaptically, changes occur in receptor function and density, such as phosphorylation and increased membrane insertion of NMDA receptors, contributing to enhanced synaptic efficacy and excitability.[5] Furthermore, inhibitory mechanisms become impaired. This "disinhibition" can result from reduced function or expression of opioid receptors on primary afferents and dorsal horn neurons, or dysfunction of GABAergic and glycinergic interneurons. A key mechanism involves a shift in the chloride ion gradient in dorsal horn neurons, such that activation of GABA A receptors becomes less hyperpolarizing or even depolarizing, reducing inhibitory control. This shift can be driven by factors like Brain-Derived Neurotrophic Factor (BDNF) released from activated microglia.[2]
- Glial Activation: Microglia and astrocytes in the spinal cord become robustly activated following peripheral nerve injury or CNS lesions leading to deafferentation. Activated glia release a host of signaling molecules, including pro-inflammatory cytokines (TNF-α, IL-1β), chemokines, ATP, growth factors (BDNF), and matrix metalloproteinases (MMPs). These glial-derived mediators act on nearby neurons to enhance excitability, facilitate synaptic transmission, impair inhibition, and promote structural plasticity, thereby playing a crucial role in the initiation and maintenance of central sensitization and neuropathic pain.[2]
Supraspinal Contributions
Deafferentation induces significant plastic changes in brain structures involved in sensory processing and pain perception.
- Thalamic Changes: The thalamus, a critical relay station for sensory information, undergoes significant alterations. Deafferented thalamic neurons, particularly in the somatosensory nuclei (e.g., VPL/VPM), can develop spontaneous hyperactivity and burst firing patterns.[2] Structural changes, including neuronal atrophy and volume reduction in deafferented thalamic regions, have also been observed following SCI and amputation.[1] These thalamic changes likely contribute to spontaneous pain and altered sensory processing.
- Cortical Reorganization: One of the most studied supraspinal consequences of deafferentation is the reorganization of cortical maps in the primary somatosensory (S1) and motor (M1) cortices.[2] Following loss of input from a body part (e.g., amputation, SCI), the cortical area previously representing that part becomes responsive to input from adjacent body regions. For instance, after arm amputation, the S1/M1 hand area may become activated by stimulation of the face or residual limb stump.[1] This reorganization involves both rapid functional unmasking of pre-existing, normally latent connections and slower structural changes, such as sprouting of new axonal connections into the deafferented cortical territory.[7] The extent of this reorganization has been linked to pain intensity in some studies.[1]
- Pain Matrix Involvement: The experience of pain involves a network of brain regions often termed the "pain matrix," which includes areas involved in sensory-discriminative aspects (S1, S2, posterior insula, thalamus) and affective-motivational aspects (anterior cingulate cortex (ACC), anterior insula, prefrontal cortex). Deafferentation-induced changes in thalamic activity and cortical organization are thought to interact with this network. Altered inputs from reorganized S1/M1 or dysfunctional thalamocortical loops may drive abnormal activity within the pain matrix, contributing to the perception of pain and its unpleasantness. Psychological factors can also modulate activity within these regions.[1]
- Thalamocortical Dysrhythmia (TCD): This theory proposes that deafferentation leads to abnormal, low-frequency (theta band) oscillatory activity in thalamocortical circuits. Reduced afferent input causes thalamic neurons to enter a state of hyperpolarization-induced burst firing, which drives synchronized theta oscillations in the cortex. This dysrhythmic activity is hypothesized to underlie positive symptoms like pain (via activation of surrounding intact cortical areas - the "edge effect") and negative symptoms like sensory loss. EEG studies in patients with SCI-related CNP showing increased theta power and decreased alpha frequency provide support for this model.[8]
Maladaptive Plasticity and Cortical Reorganization
The relationship between cortical reorganization and deafferentation pain, particularly PLP, has been a subject of intense research and some debate.
- Evidence Linking Reorganization to Pain: Numerous studies, primarily using functional neuroimaging (fMRI, MEG) and transcranial magnetic stimulation (TMS), have demonstrated a correlation between the magnitude of cortical map shifts (e.g., face representation expanding into the hand area in S1/M1 after arm amputation) and the intensity or unpleasantness of ongoing PLP. Similar correlations have been found between S1 reorganization and pain in SCI patients.[1] Furthermore, therapeutic interventions that successfully alleviate deafferentation pain, such as mirror therapy, mental imagery, motor cortex stimulation, or successful prosthesis use, have been associated with a reduction or reversal of this cortical reorganization.[12] This temporal association strengthens the link between cortical plasticity and the pain experience.
- Controversy and Alternative Views: Despite these correlations, a direct causal link remains debated. Some studies have failed to find a significant correlation between the extent of reorganization and pain ratings.[13] Methodological differences in measuring reorganization might contribute to discrepancies. Moreover, some research suggests that chronic pain after amputation or SCI might be associated with a shrinkage or reduced excitability of the deafferented cortical representation, rather than expansion. A study comparing neuropathic (trigeminal neuropathy) and non-neuropathic (TMD) chronic orofacial pain found reorganization only in the neuropathic group, suggesting the plasticity is linked to the nerve lesion itself, not just the presence of pain. However, even in that study, the degree of reorganization did not correlate with pain intensity.[14] It remains unclear whether reorganization is the primary driver of pain or an epiphenomenon reflecting the underlying injury and subsequent maladaptive processes.[15] An alternative hypothesis suggests that the persistence of a vivid representation of the phantom limb in the cortex, possibly due to maintained structural integrity despite deafferentation, correlates more strongly with pain than the invasion by neighboring representations.[16] The level of the nervous system lesion might also influence the primary site of plastic changes driving cortical map alterations; for instance, reorganization after dorsal column lesions might depend more on brainstem plasticity, whereas peripheral amputation might involve more cortical sprouting.[7]
- Synthesis: Cortical reorganization is an undeniable consequence of significant deafferentation, reflecting the brain's inherent plasticity. While its precise role as a direct generator of pain intensity is complex and possibly variable across individuals and conditions, it is clearly associated with the neuropathic state following deafferentation. It may contribute to pain by creating sensory-motor conflicts (e.g., motor commands without appropriate sensory feedback)[17], altering the balance of excitation/inhibition within cortical circuits, or driving aberrant activity in the broader pain processing network.[1] It serves as a significant indicator of the maladaptive central changes that underpin deafferentation pain syndromes.
Clinical Features
History
The clinical presentation of deafferentation pain is characterized by a constellation of sensory symptoms perceived in the area of sensory loss.[1][2]
Continuous Pain: This is often the most prominent and distressing symptom. Patients typically describe the pain using descriptors characteristic of neuropathic pain, such as burning, tingling, prickling, pins-and-needles, shooting, lancinating, stabbing, electrical shock-like, squeezing, cramping, aching, or sensations of pressure or heaviness. It may involve both superficial (skin-like) and deep (muscle/bone-like) sensations. The onset of pain can be immediate following the injury or significantly delayed, sometimes appearing months or even years later.
Paroxysmal Pain: Classically in dorsal root avulsion injuries patients have both continuous and paroxysmal pain.
Non-Painful Abnormal Sensations:
- Paresthesias: Abnormal sensations that are not unpleasant, such as tingling, numbness, or "pins and needles".
- Dysesthesias: Abnormal sensations that are inherently unpleasant, whether spontaneous or evoked. Allodynia and hyperalgesia are considered special cases of evoked dysesthesia.
Examination
Evoked Pain: Pain can also be triggered or exacerbated by stimuli.
- Hyperalgesia: An exaggerated pain response to a stimulus that is normally painful (e.g., increased pain from a pinprick).
- Allodynia: Pain evoked by a stimulus that does not normally cause pain, such as light touch (e.g., from clothing or bedsheets), gentle pressure, movement, or temperature changes (especially cold).
- Hyperpathia: An abnormally painful reaction to a stimulus, often with an explosive character, delayed onset, and persistence after the stimulus is removed.
Sensory Loss: The hallmark sign is decreased or absent sensation (hypoesthesia/anesthesia for touch, vibration; hypoalgesia/analgesia for pinprick; altered thermal sensation) in the painful area. This sensory deficit must correspond neuroanatomically to the territory supplied by the damaged part of the somatosensory system (e.g., specific dermatomes, peripheral nerve distribution, or a region corresponding to a CNS lesion). The paradoxical combination of demonstrable sensory loss within the painful region is a key feature distinguishing deafferentation pain from other pain types.
Anesthesia Dolorosa: In this specific subtype, clinical examination confirms complete loss of all relevant sensory modalities (touch, pinprick, temperature) in the region where the patient reports constant pain.
Phantom Limb Phenomena
These are specific manifestations of deafferentation following limb amputation.
Phantom Limb Sensation (PLS): The non-painful feeling that the amputated limb is still present. This can include sensations of position, movement, touch, temperature, or itching in the phantom.[6] PLS is extremely common after amputation.
Phantom Limb Pain (PLP): Pain perceived as originating in the absent limb. The pain quality is often neuropathic (burning, shooting, electrical, cramping, squeezing).[1] PLP is the archetypal deafferentation pain syndrome and is distinct from RLP, although they often coexist.[6]
Diagnosis
A diagnosis of deafferentation pain is made when a patient meets criteria for definite neuropathic pain, and the clinical examination and/or investigations specifically confirm significant sensory loss (partial or complete interruption of afferent pathways) as a key feature within the painful area. The presence of pain in an area of sensory loss is the defining clinical characteristic.
IASP Neuropathic Pain Grading System: This structured approach helps determine the certainty of a neuropathic pain diagnosis :
- Step 1: Possible Neuropathic Pain: Requires (1) a history suggestive of a relevant neurological lesion or disease, AND (2) a pain distribution that is neuroanatomically plausible.
- Step 2: Probable Neuropathic Pain: Requires 'Possible NP' criteria met, PLUS (+) presence of sensory signs (negative and/or positive) consistent with the pain distribution and suspected lesion on clinical examination.
- Step 3: Definite Neuropathic Pain: Requires 'Probable NP' criteria met, PLUS (+) objective confirmation of the lesion or disease affecting the somatosensory system via diagnostic tests (e.g., imaging, neurophysiology).
Differential Diagnosis
Neuroma Pain / Residual Limb Pain
A key differential diagnosis is with neuroma pain
Pain arising directly from a damaged nerve ending (neuroma) or other structures in the residual limb (stump) after amputation or nerve injury.[15] This pain is primarily driven by peripheral mechanisms (ectopic firing from the neuroma).[6] It is typically localized to the neuroma site or stump, often exacerbated by direct pressure or movement of the stump, and may elicit a Tinel's sign (shooting pain on percussion over the nerve).[18] While sensory loss may be present distally, the pain focus is peripheral. It frequently coexists with PLP (deafferentation pain) but requires different diagnostic considerations and may respond better to peripherally targeted treatments. The dynamic interplay where RLP/neuroma pain might initially predominate or contribute to central changes leading to PLP should be recognized.[6]
Differentiating Deafferentation Pain from Neuroma Pain
Feature | Deafferentation Pain (e.g., PLP, Central Pain) | Neuroma Pain / Residual Limb Pain (RLP) |
---|---|---|
Primary Mechanism | Central maladaptive plasticity (spinal/supraspinal) due to loss of afferent input [1] | Peripheral ectopic firing from damaged nerve end / neuroma sprouts [6] |
Location of Pain | Perceived in the deafferented area (e.g., phantom limb, region below SCI) [1] | Localized to the site of nerve injury/neuroma or residual limb; may radiate along nerve [6] |
Key Sensory Finding | Significant hypoesthesia or anesthesia within the painful area [2] | Localized tenderness over neuroma; positive Tinel's sign common; distal sensation variable [18] |
Pain Character | Often spontaneous; burning, aching, tingling, squeezing, electrical [1] | Often evoked by pressure/movement; sharp, lancinating, shooting, electrical [6] |
Response to Peripheral Block | Often incomplete or transient relief[9] | Often significant, though potentially temporary, relief if block targets the neuroma/nerve [6] |
Other Differentials
Nociceptive Pain: Pain driven by ongoing activation of nociceptors in non-neural tissues due to injury or inflammation (e.g., osteoarthritis, muscle strain, visceral pain). Key differentiating features include the absence of a primary neurological lesion affecting the somatosensory system, pain typically described as aching or throbbing rather than burning or shooting, pain intensity correlating with tissue pathology or movement, and the absence of neurological sensory deficits (numbness, tingling) or signs (allodynia) in the painful area. Careful examination is needed, especially in patients with existing neurological conditions like SCI, where musculoskeletal pain is a common comorbidity.
Complex Regional Pain Syndrome (CRPS): Characterized by pain disproportionate to an inciting event, accompanied by sensory (allodynia, hyperalgesia), vasomotor (temperature/color changes), sudomotor (sweating changes/edema), and motor/trophic (weakness, tremor, dystonia, changes in hair/nail/skin) signs and symptoms. CRPS Type I occurs without demonstrable nerve injury (thus not strictly neuropathic by current IASP definition[2]), while CRPS Type II follows a specific nerve injury.[19] Deafferentation pain typically lacks the prominent autonomic and trophic features seen in CRPS, although some sensory overlap (allodynia/hyperalgesia) exists.
Other Central Pain Syndromes: Not all pain originating from CNS lesions involves deafferentation of primary sensory pathways. For example, central pain in Parkinson's disease may relate more to dopaminergic system dysfunction.[20] Differentiating these requires careful clinical correlation with the nature and location of the CNS pathology and the specific pattern of sensory symptoms and signs.
Psychogenic Pain / Somatic Symptom Disorder: Pain where psychological factors are considered the primary drivers, without sufficient evidence of an underlying neurological or tissue-based pathology. This is largely a diagnosis of exclusion made after comprehensive evaluation rules out organic causes.[21] While psychological factors significantly modulate all chronic pain experiences, including deafferentation pain [1], deafferentation pain itself is characterized by demonstrable evidence of a lesion or disease affecting the somatosensory system.
Prognosis
While the intensity may fluctuate, complete spontaneous resolution is uncommon, particularly for centrally mediated syndromes. Pain characteristics can also evolve over time; for example, PLP may initially be sharp or lancinating but later become predominantly burning or squeezing.[1]
Long-term outcomes following treatment are highly variable and often suboptimal.[22] Even interventions considered effective, such as DREZ lesioning for BPA or MVD for trigeminal neuralgia (which carries a risk of AD if ablative), demonstrate diminishing pain relief or recurrence over extended follow-up periods.[23] DREZ lesioning does however appear to have a large effect size for both the continuous and paroxysmal aspects of dorsal root avulsion pain.[24] For neuromodulation techniques like MCS, efficacy may wane but can sometimes be recaptured by reprogramming stimulation parameters.[25]
Observational studies suggest that patients with central neuropathic pain syndromes (e.g., Central Post Stroke Pain, Spinal Cord Injury pain) managed in specialized tertiary care settings tend to have poorer long-term outcomes in terms of achieving clinically significant reductions in pain intensity and pain-related interference compared to patients with peripheral neuropathic pain conditions.[26] This highlights the particular intractability of pain arising from CNS lesions and underscores the need for realistic expectations and potentially different management strategies for central versus peripheral deafferentation pain.
References
- ā 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 Hanakawa, Takashi (2012 Apr 11). "Neural mechanisms underlying deafferentation pain: a hypothesis from a neuroimaging perspective". Journal of Orthopaedic Science (in English). 17 (3): 331. doi:10.1007/s00776-012-0209-9. PMID 22491886. Check date values in:
|date=
(help) - ā 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 Finnerup, Nanna Brix; Kuner, Rohini; Jensen, Troels Staehelin (2021-01-01). "Neuropathic Pain: From Mechanisms to Treatment". Physiological Reviews (in English). 101 (1): 259ā301. doi:10.1152/physrev.00045.2019. ISSN 0031-9333.
- ā Marbach, Joseph J.; Raphael, Karen G. (2000-03). "Phantom Tooth Pain: A New Look at an Old Dilemma". Pain Medicine (in English). 1 (1): 68ā77. doi:10.1046/j.1526-4637.2000.00012.x. ISSN 1526-2375. Check date values in:
|date=
(help) - ā 4.0 4.1 4.2 Rosner, Jan; Andrade, Daniel C. de; Davis, Karen D.; Gustin, Sylvia M.; Kramer, John L. K.; Seal, Rebecca P.; Finnerup, Nanna B. (2023 Dec 21). "Central neuropathic pain". Nature reviews. Disease primers (in English). 9 (1): 73. doi:10.1038/s41572-023-00484-9. PMID 38129427. Check date values in:
|date=
(help) - ā 5.0 5.1 5.2 5.3 5.4 Costigan, Michael; Scholz, Joachim; Woolf, Clifford J. (2009-06-01). "Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage". Annual Review of Neuroscience. 32 (1): 1ā32. doi:10.1146/annurev.neuro.051508.135531. ISSN 0147-006X.
- ā 6.00 6.01 6.02 6.03 6.04 6.05 6.06 6.07 6.08 6.09 6.10 Cohen, Steven; Hsu (2013-02). "Postamputation pain: epidemiology, mechanisms, and treatment". Journal of Pain Research: 121. doi:10.2147/jpr.s32299. ISSN 1178-7090. Check date values in:
|date=
(help) - ā 7.0 7.1 7.2 Moore, Christopher I.; Stern, Chantal E.; Dunbar, Carolyn; Kostyk, Sandra K.; Gehi, Anil; Corkin, Suzanne (2000-12-12). "Referred phantom sensations and cortical reorganization after spinal cord injury in humans". Proceedings of the National Academy of Sciences. 97 (26): 14703ā14708. doi:10.1073/pnas.250348997. ISSN 0027-8424.
- ā 8.0 8.1 Anderson, Keri; Stein, Sebastian; Suen, Ho; Purcell, Mariel; Belci, Maurizio; McCaughey, Euan; McLean, Ronali; Khine, Aye; Vuckovic, Aleksandra (2025-01-16). "Generalisation of EEG-Based Pain Biomarker Classification for Predicting Central Neuropathic Pain in Subacute Spinal Cord Injury". Biomedicines. 13 (1): 213. doi:10.3390/biomedicines13010213. ISSN 2227-9059.
- ā 9.0 9.1 Rhodes Lee-Ann. Phantom Limb Pain textbook chapter.https://tumorsurgery.org/Portals/0/PDF/Textbooks/ch24.pdf
- ā Guenot, Marc; Bullier, Jean; Sindou, Marc (2002-12). "Clinical and electrophysiological expression of deafferentation pain alleviated by dorsal root entry zone lesions in rats". Journal of Neurosurgery. 97 (6): 1402ā1409. doi:10.3171/jns.2002.97.6.1402. ISSN 0022-3085. PMID 12507140. Check date values in:
|date=
(help) - ā Ma, Yan-chao; Kang, Ze-biao; Shi, Yong-qiang; Ji, Wen-yi; Zhou, Wen-ming; Nan, Wei (2024-04-25). "The Complexity of Neuropathic Pain and Central Sensitization: Exploring Mechanisms and Therapeutic Prospects". Journal of Integrative Neuroscience. 23 (5). doi:10.31083/j.jin2305089. ISSN 0219-6352.
- ā Xu, Wen-Dong (2014-01-14). "Deactivation of Distant Pain-Related Regions Induced by 20-day rTMS: A Case Study of Oneweek Pain Relief for Long-Term Intractable Deafferentation Pain". Pain Physician. 17, 1 (1, 17): E99āE105. doi:10.36076/ppj.2014/17/e99. ISSN 2150-1149. line feed character in
|title=
at position 45 (help) - ā Flor, Herta (2003-10-01). "Cortical reorganisation and chronic pain: implications for rehabilitation". Journal of Rehabilitation Medicine. 35 (0): 66ā72. doi:10.1080/16501960310010179. ISSN 1650-1977.
- ā Devor, Marshall (2012-11-27). "Faculty Opinions recommendation of Pain and plasticity: is chronic pain always associated with somatosensory cortex activity and reorganization?". Faculty Opinions ā Post-Publication Peer Review of the Biomedical Literature. Retrieved 2025-05-13.
- ā 15.0 15.1 Cohen, Steven P.; Caterina, Michael J.; Yang, Su-Yin; Socolovsky, Mariano; Sommer, Claudia (2024-04). "Pain in the Context of Sensory Deafferentation". Anesthesiology (in English). 140 (4): 824ā848. doi:10.1097/ALN.0000000000004881. ISSN 0003-3022. Check date values in:
|date=
(help) - ā Makin, Tamar R.; Scholz, Jan; Henderson Slater, David; Johansen-Berg, Heidi; Tracey, Irene (2015-06-13). "Reassessing cortical reorganization in the primary sensorimotor cortex following arm amputation". Brain. 138 (8): 2140ā2146. doi:10.1093/brain/awv161. ISSN 0006-8950.
- ā Swiontkowski, M.F. (2009-01). "Phantom limb pain, cortical reorganization and the therapeutic effect of mental imagery". Yearbook of Orthopedics. 2009: 74ā76. doi:10.1016/s0276-1092(09)79549-5. ISSN 0276-1092. Check date values in:
|date=
(help) - ā 18.0 18.1 Power, Dominic; Curtin, Catherine; BellemĆØre, Philippe; Nyman, Erika; Pajardi, Giorgio; Isaacs, Jonathan; Levin, Lawrence Scott (2023-07). "Surgical Treatment of Symptomatic End-Neuroma With a New Bioresorbable Copolyester Nerve Capping Device: A Multicenter Prospective Cohort Study". Annals of Plastic Surgery (in English). 91 (1): 109ā116. doi:10.1097/SAP.0000000000003596. ISSN 1536-3708. Check date values in:
|date=
(help) - ā Hurley Robert. Neuropathic Pain Syndormes textbook chapter. https://pcpr.pitt.edu/wp-content/uploads/2018/01/Hurley-Henriques-Wu-2007.pdf
- ā Kim, Sooyoung; Jeong, Hye Seon; Lee, Ae Young; Sohn, Eunhee (2025-01). "Non-invasive brain stimulation for central neuropathic pain: a preliminary study". Brain Stimulation. 18 (1): 431. doi:10.1016/j.brs.2024.12.640. ISSN 1935-861X. Check date values in:
|date=
(help) - ā Treede, Rolf-Detlef (2018 Mar 5). "The International Association for the Study of Pain definition of pain: as valid in 2018 as in 1979, but in need of regularly updated footnotes". Pain Reports (in English). 3 (2): e643. doi:10.1097/PR9.0000000000000643. PMID 29756089. Check date values in:
|date=
(help) - ā Backonja, Misha-Miroslav; Serra, Jordi (2004-03). "Pharmacologic Management Part 2: Lesser-Studied Neuropathic Pain Diseases". Pain Medicine. 5 (suppl 1): S48āS59. doi:10.1111/j.1526-4637.2004.04021.x. ISSN 1526-2375. Check date values in:
|date=
(help) - ā Ruiz-Juretschke, F.; GarcĆa-Salazar, F.; GarcĆa-Leal, R.; FernĆ”ndez-Carballal, C.; Iza, B.; Garbizu, J.M.; GarcĆa-Duque, S.; Panadero, T. (2011). "Treatment of neuropathic deafferentation pain using DREZ lesions; long-term results". NeurologĆa (English Edition). 26 (1): 26ā31. doi:10.1016/s2173-5808(11)70005-0. ISSN 2173-5808.
- ā Lubelski, Daniel; Pennington, Zach; Ochuba, Arinze J.; Khalifeh, Jawad; Al-Mistarehi, Abdel-Hameed; Belzberg, Allan J. (2023-07-01). "Is dorsal root entry zone lesioning effective and safe for managing continuous versus paroxysmal pains postābrachial plexus avulsion?". Journal of Neurosurgery: Spine. 39 (1): 101ā112. doi:10.3171/2023.2.spine221252. ISSN 1547-5654.
- ā Hussein, Ahmed E.; Esfahani, Darian R.; Moisak, Galina I.; Rzaev, Jamil A.; Slavin, Konstantin V. (2018-05-23). "Motor Cortex Stimulation for Deafferentation Pain". Current Pain and Headache Reports. 22 (6): 45. doi:10.1007/s11916-018-0697-1. ISSN 1534-3081. PMID 29796941.
- ā Staudt, Michael D.; Clark, Alexander John; Gordon, Allan S.; Lynch, Mary E.; Morley-Forster, Pat K.; Nathan, Howard; Smyth, Catherine; Stitt, Larry W.; Toth, Cory; Ware, Mark A.; Moulin, Dwight E. (2018-09). "Long-Term Outcomes in the Management of Central Neuropathic Pain Syndromes: A Prospective Observational Cohort Study". Canadian Journal of Neurological Sciences (in English). 45 (5): 545ā552. doi:10.1017/cjn.2018.55. ISSN 0317-1671. Check date values in:
|date=
(help)